MedicaMetrix, Inc., a leader in developing and marketing innovative medical devices and healthcare solutions, has experienced rapid growth in multiple product lines from prostate health management to catheter and IV securement devices. In order to support the current growth and impending international expansion, the company has established an Executive Leadership structure in recent months.
Vyda Bielkus is spearheading MedicaMetrix’s Strategy and Business Development efforts with her 20+ years’ experience scaling startups from idea stage through scale up to growth stage companies. With a wide range of experience across healthcare, technology, and wellness industry verticals, she brings extensive strategic growth, product management and business development expertise. Vyda holds a MBA with an additional Healthcare Certificate from the MIT Sloan School of Management and a BA in Economics from Wellesley College.
Paul Edwards has expanded his role to Executive Vice President, Capital Markets, and CFO of MedicaMetrix. Prior to MedicaMetrix, Mr. Edwards served as a partner at Capri Capital Partners, the $3.6 Billion real estate asset management firm, where he oversaw the firm’s investment and marketing activities, in addition to spearheading initiatives in Africa, India and the Middle East. Mr. Edwards is also the President and Chief Executive Officer of Capri Africa, and a member of the Global Management Board.
Mary Kilwien brings her expertise as Executive Vice President of Strategic Alliances & Investor Relations. In her role, Mary is responsible for establishing partnerships globally with healthcare and research institutions, associations, and industry leaders. Mary co-founded and served as Chief Marketing Officer for the London-based Smalls and Walker, an innovative natural cosmetics company. She developed and nurtured a niche brand, managed channels, established strategic partnerships, introduced the first line of cruelty-free aromatherapy products, and created a private label sold exclusively through Nordstrom. Early on in her career, Mary marketed technology-based communication systems to Fortune 500 companies. Mary brings a wide network of not-for-profit institutions, funds, and family offices.
“MedicaMetrix is on the cusp of international expansion of multiple medical products, brands and technologies,” Satish Vankayalapati, Chairman and Founder of MedicaMetrix stated. “We feel that the establishment of an experienced and effective Executive Leadership team is essential in allowing us to change how the world approaches, diagnoses and treats prostate health.”
The company continues its aggressive growth in domestic and international environments under the ongoing leadership of Mr. Vankayalapati, Robert J Rudelius: President & CEO, Christopher Lafarge: Chief Operating Officer, and Peter Madras M.D. : Chief Medical Officer, among others.
